Fat Loss
Retatrutide 10mg
One of the most closely watched compounds in metabolic research. Studied for how it acts on the body's fat-storage, blood-sugar, and energy-use pathways. Research-grade Retatrutide (LY3437943) is a synthetic 39-amino-acid triple GLP-1/GIP/glucagon receptor agonist peptide.
$90.00
Add this and you're $50.00 away from free shipping
- Third-Party Tested
- 99%+ Purity
- COA Included
Certificate of Analysis
- Purity (HPLC)
- 99%+
- Format
- Lyophilized powder
- Storage
- −20°C (long-term)
- Shipping
- Canadian domestic
- Testing
- HPLC purity + content
This batch's COA publishes here the day Janoshik files results — track it on Lab Reports.
About Retatrutide 10mg
Retatrutide (LY3437943) is a triple-receptor agonist. It targets GLP-1, GIP, and glucagon receptors at the same time — which sets it apart from dual-agonist compounds.
Preclinical research has explored its role in fat-tissue loss, insulin sensitivity, and how much energy the body burns. That triple-agonist profile makes it a compound of interest in metabolic syndrome research.
Comes as lyophilized powder in 10 mg and 30 mg sizes. Mix with bacteriostatic water before use in a research protocol.
Molecular Information
- Formula
- C₂₃₂H₃₄₆N₅₆O₇₁S₂
- Mol. Weight
- ≈ 4,914 Da
- Sequence length
- 39 amino acids
- Half-life (est.)
- ≈ 6 days (sc)
- CAS / Registry
- LY3437943
- For laboratory research use only.
- Not for human or veterinary use.
- Not intended for diagnosis, treatment, cure, or prevention of any disease.
- Use only in a controlled lab setting, and only by trained staff.
Research Profile
preclinical research consensus for informational comparison only
Research context
Pairs With
For research purposes only. Not for human consumption. All products are sold strictly as research chemicals for in vitro laboratory use.